User profiles for P. von Dadelszen

Peter von Dadelszen

King's College London
Verified email at kcl.ac.uk
Cited by 55333

Pre-eclampsia

EAP Steegers, P Von Dadelszen, JJ Duvekot… - The lancet, 2010 - thelancet.com
Pre-eclampsia remains a leading cause of maternal and perinatal mortality and morbidity. It
is a pregnancy-specific disease characterised by de-novo development of concurrent …

Preeclampsia

…, KH Nicolaides, P Von Dadelszen - New England Journal of …, 2022 - Mass Medical Soc
Preeclampsia Preeclampsia complicates 2 to 4% of all pregnancies and accounts for about
46,000 maternal deaths and 500,000 fetal or newborn deaths each year. Antihypertensive …

[HTML][HTML] Effects of the COVID-19 pandemic on maternal and perinatal outcomes: a systematic review and meta-analysis

…, K Le Doare, S Ladhani, P von Dadelszen… - The Lancet Global …, 2021 - thelancet.com
… We reported p values and the amount of accounted heterogeneity for each covariate.
Potential publication bias was assessed with Egger's test and funnel plots for visual inspection …

COVID-19 vaccination during pregnancy: coverage and safety

…, P O'brien, A Rezvani, P von Dadelszen… - American journal of …, 2022 - Elsevier
… vaccine uptake in younger women (P=.001), high levels of deprivation (P=.008), and Afro-Caribbean
or Asian ethnicity compared with White or mixed ethnic background (P<.001). …

Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis

P Von Dadelszen, MP Ornstein, SB Bull, AG Logan… - The Lancet, 2000 - thelancet.com
Background We investigated the relation between fetoplacental growth and the use of oral
antihypertensive medication to treat mild-to-moderate pregnancy hypertension. Methods The …

Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary

…, A Pels, M Helewa, E Rey, P von Dadelszen… - Journal of Obstetrics and …, 2014 - Elsevier
Objective This executive summary presents in brief the current evidence assessed in the
clinical practice guideline prepared by the Canadian Hypertensive Disorders of Pregnancy …

[HTML][HTML] The International Federation of Gynecology and Obstetrics (FIGO) initiative on preeclampsia (PE): a pragmatic guide for first trimester screening and …

…, F da Silva Costa, P Von Dadelszen… - … of gynaecology and …, 2019 - ncbi.nlm.nih.gov
Preeclampsia (PE) is a multisystem disorder that typically affects 2%− 5% of pregnant
women and is one of the leading causes of maternal and perinatal morbidity and mortality, …

[HTML][HTML] Systematic review and meta-analysis of the effectiveness and perinatal outcomes of COVID-19 vaccination in pregnancy

…, P von Dadelszen, LA Magee, P Heath… - Nature …, 2022 - nature.com
Safety and effectiveness of COVID-19 vaccines during pregnancy is a particular concern
affecting vaccination uptake by this vulnerable group. Here we evaluated evidence from 23 …

Subclassification of preeclampsia

P Von Dadelszen, LA Magee… - Hypertension in …, 2003 - Taylor & Francis
Preeclampsia is a heterogeneous disorder, and as with other diseases (eg, type I and type II
diabetes), progress in the understanding of this disorder would be assisted greatly if …

Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model

P von Dadelszen, B Payne, J Li, JM Ansermino… - The Lancet, 2011 - thelancet.com
Background Pre-eclampsia is a leading cause of maternal deaths. These deaths mainly result
from eclampsia, uncontrolled hypertension, or systemic inflammation. We developed and …